Evaluation of anti-sleeping-sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 6, 2009, Pages 1293-1295

  Steverding, Dietmar ^a   Wang, Xia ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

DNA topoisomerase inhibitors; Drug combinations; T. brucei

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ACLARUBICIN; DAUNORUBICIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; EFLORNITHINE; EPIRUBICIN; GYRASE INHIBITOR; IDARUBICIN; MELARSOPROL; MITOXANTRONE; NIFURTIMOX; PENTAMIDINE; SURAMIN; TOPOTECAN;

AFRICAN TRYPANOSOMIASIS; ANTIPROTOZOAL ACTIVITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG SELECTIVITY; GROWTH INHIBITION; HUMAN; LETTER; MALIGNANT NEOPLASTIC DISEASE; MONOTHERAPY; NONHUMAN; RISK REDUCTION;

ANIMALS; ANTIPROTOZOAL AGENTS; DRUG SYNERGISM; ENZYME INHIBITORS; HUMANS; INHIBITORY CONCENTRATION 50; PARASITIC SENSITIVITY TESTS; TRYPANOSOMA BRUCEI BRUCEI;

EID: 65749088876     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp120     Document Type: Letter

References (9)

1. Fairlamb AH. Chemotherapy of human African trypanosomiasis: Current and future prospects. Trends Parasitol 2003; 19: 488-94.
2. Barrett SV, Barrett MP. Anti-sleeping sickness drugs and cancer chemotherapy. Parasitol Today 2000; 16: 7-9.
3. Deterding A, Dungey FA, Thompson KA et al. Anti-trypanosomal activities of DNA topoisomerase inhibitors. Acta Trop 2005; 93 311-6.
4. Topcu Z. DNA topoisomerases as targets for anticancer drugs. J Clin Pharm Ther 2001; 26: 405-16.
5. Priotto G, Fogg C, Balasegaram M et al. Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: A randomized clinical trial in Uganda. PLoS Clin Trials 2006; 1 e39.
6. Bisser S, N'Siesi FX, Lejon V et al. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness. J Infect Dis 2007; 195: 322-9.
7. Priotto G, Kasparian S, Ngouama D et al. Nifurtimox-eflomithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: A randomized clinical trial in Congo. Clin Infect Dis 2007; 45: 1435-42.
8. Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006; 58: 621-81.
9. Hirumi H, Hirumi K, Doyle JJ et al. In vitro cloning of animal-infective bloodstream forms of Trypanosoma brucei. Parasitology 1980; 80: 371-82.